Zoetis Inc. ZTS
$77.03▼ -2.25% 24H
Super Investor & Insider
3
Fondi che lo detengono
#279
Rank consenso
4.3%
% dei portafogli
$548.5M
Valore detenuto
| Fondo | % portaf. | Attività | Azioni | Valore |
|---|---|---|---|---|
| Polen Capital Management · Polen Capital Management | 3.45% | Reduce 24.08% | 4,223,076 | $499.2M |
| Mairs & Power · Mairs & Power | 0.37% | Add 33.89% | 303,116 | $35.8M |
| David Rolfe · Wedgewood Partners | 2.77% | Add 8.44% | 113,541 | $13.4M |
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Zoetis Inc. is a global animal health company that discovers, develops, manufactures, and commercializes medicines, vaccines, diagnostics, biodevices, genetic tests, and precision animal health solutions. Its products serve both companion animals, such as dogs, cats, and horses, and livestock, including cattle, swine, …
SectorHealthcare
ExchangeNYSE
IndustryDrug Manufacturers - Specialty & Generic
CountryUnited States
Employees14,500
TickerZTS
Statistics
Market Cap$32.38B
Revenue (TTM)$9.47B
Net Income$2.67B
Net Margin28.2%
EPS$6.02
P/E13.16
P/S3.53
P/B10.24
EV/EBITDA10.16
ROE67.7%
Dividend Yield2.60%
Price$77.03
Data: Twelve Data · Revenue = mcap / P/S